Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.
NANO-X IMAGING LTD (Nanox) (NASDAQ: NNOX) is a medical imaging technology company that combines imaging hardware, AI-based software, cloud infrastructure, and teleradiology services. The Nanox news feed on this page aggregates company press releases and market updates so readers can follow how Nanox advances its imaging platform, commercial strategy, and capital markets activity over time.
Nanox’s recent news highlights its Nanox.ARC and Nanox.ARC X multi-source digital tomosynthesis systems, including CE Mark certification for Nanox.ARC in Europe and FDA 510(k) clearance for Nanox.ARC X for general use in multiple clinical indications. Articles also cover distribution agreements and collaborations with partners in countries such as France, the Czech Republic, Greece, Romania, Serbia, Montenegro, and Bosnia and Herzegovina, reflecting efforts to expand clinical and commercial deployment of its imaging solutions.
Another key news theme is the growth of Nanox.AI and its imaging analytics portfolio. Press releases describe AI algorithms that analyze routine CT scans for early signs associated with chronic diseases and bone health solutions such as HealthVCF and HealthOST, which have been included in an Early Value Assessment by the UK National Institute for Health and Care Excellence. Updates also discuss acquisitions like VasoHealthcare IT, intended to support deployment of AI solutions across U.S. healthcare facilities.
Investors and analysts can also find financial results announcements, guidance updates, and details of registered direct offerings and other financings, as reported in Nanox’s press releases and related SEC filings. Together, these news items provide insight into Nanox’s commercialization progress, clinical collaborations, AI development roadmap, and capital strategy. Bookmark this page to access an organized stream of Nanox news, from product and partnership updates to financial and regulatory disclosures.
NANO-X IMAGING LTD (NNOX) has entered the West African market by signing an exclusive distribution agreement with EiLEENO Pharma to deploy 1,000 Nanox Systems in Nigeria, pending regulatory approval. This collaboration aims to enhance medical imaging availability and improve healthcare standards in the country. The agreement has a four-year term with annual service fees from EiLEENO Pharma. The Nanox System includes the innovative Nanox.ARC imaging device and Nanox.CLOUD software, which promises to facilitate accessible healthcare services across roughly 4,400 health facilities in Nigeria.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced that CEO Ran Poliakine will present at the Ladenburg Thalmann Healthcare Conference on July 14, 2021, at 10:00 AM ET. The live presentation can be accessed through a webcast, and a replay will be available after the event. Nanox focuses on developing a digital X-ray source aimed at reducing medical imaging costs and providing affordable early detection services. Interested parties can find more details on the company's investor relations website.
NANOX IMAGING LTD (NASDAQ: NNOX) announced a significant milestone by submitting a 510(k) premarket notification to the FDA for its multi-source Nanox.ARC 3-D digital tomosynthesis system. This system aims to address the global need for accessible and cost-effective medical imaging. The submission is a crucial step in the U.S. regulatory process following the FDA clearance of its single source Nanox Cart X-Ray System in April 2021. NANOX plans to develop future versions of the Nanox.ARC to fulfill existing service contracts and collaborations.
NANO-X IMAGING LTD (NASDAQ: NNOX) announces that Chairman and CEO Ran Poliakine will present at the Jefferies Virtual Healthcare Conference from June 1-4, 2021. Poliakine's presentation is set for June 4 at 10:00 AM ET and will be available via a live webcast on the company's website. Nanox aims to develop a commercial-grade digital X-ray technology to reduce medical imaging costs and improve early detection services. The webcast replay will be available post-presentation. For further information, visit www.nanox.vision.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced that CEO Ran Poliakine will present at the Jefferies Virtual Healthcare Conference from June 1-4, 2021. His presentation is set for June 3 at 4:30 PM ET, accessible via a live webcast at wsw.com. The company aims to revolutionize medical imaging with its innovative digital X-ray technology, potentially reducing costs and improving early detection services globally. More information can be found on their website, nanox.vision.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced that CEO Ran Poliakine will present at the Berenberg Virtual Conference from May 18-20, 2021. Poliakine's presentation is set for May 19 at 9:00am ET and will be available via a live webcast. Interested stakeholders can access the audio from the Investor Relations section of Nanox's website, where a replay will also be available. Nanox is developing a digital X-ray source aimed at reducing medical imaging costs and is looking to collaborate with leading healthcare organizations.
Nano-X Imaging announced FDA 510(k) clearance for its Nanox Cart X-Ray System on April 2, 2021, marking a significant milestone. The company aims to submit approval for its multi-source device later this year. Despite progress, shipment of 1,000 multi-source units originally scheduled for Q1 2022 will be delayed. The company ended Q1 2021 with $219 million in cash, up from $7.4 million net loss in Q1 2020. Increases in R&D and administrative expenses were noted, with a total net loss of $12.7 million for the quarter, compared to previous losses.
NANOX IMAGING LTD (NASDAQ: NNOX) appointed Moshe Shtengel as Chief Business Officer on May 2, 2021. With extensive experience in medical business development, Shtengel previously led sales and marketing at Tuttnauer and held key positions at Lumenis and Truphatek. His expertise is expected to enhance Nanox's commercial strategy as they prepare for the launch of their novel Nanox.ARC digital x-ray technology, which has received FDA clearance. The company aims to democratize medical imaging globally.
Nano-X Imaging Ltd (NASDAQ: NNOX) will announce its first quarter 2021 financial results on May 11, 2021, prior to market trading. A conference call will follow at 8:30 AM ET to discuss these results. The company focuses on innovative medical imaging technology, aiming to reduce costs associated with medical imaging systems. Founded by Ran Poliakine, Nano-X intends to collaborate with leading healthcare organizations for affordable imaging services. Further information is available on their website.
Nano-X Imaging Ltd (NASDAQ: NNOX) has filed its annual report on Form 20-F for the fiscal year ending December 31, 2020, with the SEC on April 6, 2021. The report includes audited consolidated financial statements, accessible on the SEC's website and Nano-X’s official site. The company emphasizes its mission to democratize healthcare through innovative medical imaging technology, which aims to make imaging services more affordable. Shareholders can request a hard copy of the report free of charge by contacting Investor Relations.